Journals / Kadın Doğum Dergisi / 2006 / Cilt: 5 - Sayı: 2

HPV, Cervikal cancer and HPV Vaccines; A review

HPV, Serviks kanseri ve HPV aşıları; Derleme

Pages
1071–1076
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to evaluate the efficacy and role of vaccination in the prevention of cervical cancer along with the possible problems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: After the recent approval of prophylactic vaccines for HPV infection in our country, the utilisation of the vaccine and notification of the community have become an important responsibility for the clinicians.
📊
Key Findings & Data:The characteristics of the vaccine and suggestions for usage will come up as important topics as well as cervical cancer and the characteristics of the disease itself, preinvasive cervical lesions, the diseases associated with HPV and the role of HPV in cancer.
💡
Conclusion & Impact:The aim of this review is to evaluate the efficacy and role of vaccination in the prevention of cervical cancer along with the possible problems.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: After the recent approval of prophylactic vaccines for HPV infection in our country, the utilisation of the vaccine and notification of the community have become an important responsibility for the clinicians. The characteristics of the vaccine and suggestions for usage will come up as important topics as well as cervical cancer and the characteristics of the disease itself, preinvasive cervical lesions, the diseases associated with HPV and the role of HPV in cancer. Furthermore, it is not unexpected for the medical professionals to be faced with many questions and demands from families and other members of the society. The aim of this review is to evaluate the efficacy and role of vaccination in the prevention of cervical cancer along with the possible problems.

Özet

Amaç: Profilaktik HPV aşılarının ülkemizde de onay alması sonrası klinisyenlerin hizmetinde olacağı bugünlerde kullanım ve toplum bilgilendirilmesi önemli bir görev olarak belirmektedir. Aşının özellikleri ve kullanım önerilerinin yanında serviks kanseri, bu hastalığın özellikleri, serviksin preinvazif hastalıkları, HPV ye bağlı hastalıklar ve kanserdeki rolü tıp mensupları arasında ve toplum bazında önemli bir konu olacaktır. Toplum özellikleri açısından değerlendirildiğinde tıp mensuplarının aileler ve diğer toplum üyelerince yöneltilecek soru ve taleplerle karşı karşıya kalacağı bilinmektedir. Bu derlemenin amacı bütün bu sorularla birlikte serviks kanserinden korunmada aşının etkinliğini ve yerini olası problemlerle birlikte değerlendirmektir.

🔖

Cite This Article

DELİER, H., BAYKAL, C., ARIOĞLU, P. (2022). HPV, Cervikal cancer and HPV Vaccines; A review. Kadın Doğum Dergisi, Cilt: 5 - Sayı: 2, 1071–1076. https://ajindex.com/articles/569005

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cates, W., Jr., Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis, 1999.26(4 Suppl): p. S2-7. Pitts, M. and T. Clarke, Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res, 2002.17(6): p. 706-14.
  2. Dell, D.L., et al, Knowledge about human papillomavirus among adolescents. Obstet Gynecol, 2000.96(5 Pt 1): p. 653-6.
  3. Blake, D.R., B.M. Weber, and K.E. Fletcher, Adolescent and young adult women's misunderstanding of the term Pap smear. Arch Pediatr Adolesc Med, 2004.158(10): p. 966-70.
  4. Waller, J., K. McCaffery, and J. Wardle, Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med, 2004.38(6): p. 745-53.
  5. Holcomb, B., et al., Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract, 2004. 17(1):p. 26-31.
  6. Anhang, R., et al., Women's desired information about human papillomavirus. Cancer, 2004.100(2): p. 315 -20. Kalın, J.A., et al., Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health, 2005.37(6): p. 502-10.
  7. Riedesel, J.M., et al., Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol, 2005. 18(6):p.391-8.
  8. Collins, Y., et al., Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol, 2006. 102(3): p. 552-62.
  9. Myers, E.R., et al., Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol, 2000.151(12):p. 1158-71.
  10. Walboomers, J.M., et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999. 189(1): p. 12-9.
  11. IARC, Human Papillomaviruses, in IARC Monographs on the evaluation of carcinogenic risks to humans. 1995, IARC Press:
  12. Lyon. Munoz, N., et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003.348(6): p. 518-27. American Cancer Society. Cancer Facts &Figures 2005.2005: American Cancer Society. 1-60. 16-Zimmerman, R.K., Ethical analysis of HPV vaccine policy options. Vaccine, 2006.24(22): p. 4812-20.
  13. Winer, R.L., et al., Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol, 2003.157(3): p. 218-26.
  14. Ho, G.Y., et al.,